Wikidata entity: Q19856779
C₁₅H₁₈N₄O₅ (P274)
Quantities
| P2067 | mass | 334.12772 |
| P3780 | active ingredient in | ... | Q47521856 (Mutamycin) | Mutamycin |
| P233 | canonical SMILES | String | CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N | ??? |
| P1889 | different from | ... | Q417625 (mitomycins) | mitomycins |
| P703 | found in taxon | ... | Q146935 (Cedrus deodara) | Cedrus deodara |
| P703 | found in taxon | ... | Q7787299 (Scoparia dulcis) | Scoparia dulcis |
| P703 | found in taxon | ... | Q21319395 (Streptomyces lavendulae) | Streptomyces lavendulae |
| P703 | found in taxon | ... | Q1144013 (Streptomyces) | Streptomyces |
| P703 | found in taxon | ... | Q26293308 (Streptomyces violaceus) | Streptomyces violaceus |
| P703 | found in taxon | ... | Q7623380 (Streptomyces caespitosus) | Streptomyces caespitosus |
| P703 | found in taxon | ... | Q25864208 (Micromonospora yangpuensis) | Micromonospora yangpuensis |
| P703 | found in taxon | ... | Q26292047 (Streptomyces purpurascens) | Streptomyces purpurascens |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q504775 (bladder cancer) | bladder cancer |
| P2175 | medical condition treated | ... | Q159701 (glaucoma) | glaucoma |
| P2175 | medical condition treated | ... | Q12048781 (large intestine cancer) | large intestine cancer |
| P2175 | medical condition treated | ... | Q18556933 (cribriform carcinoma) | cribriform carcinoma |
| P361 | part of | ... | Q22276183 (mitomycin C metabolic process) | mitomycin C metabolic process |
| P361 | part of | ... | Q22276184 (mitomycin C catabolic process) | mitomycin C catabolic process |
| P361 | part of | ... | Q22276439 (mitomycin C biosynthetic process) | mitomycin C biosynthetic process |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P769 | significant drug interaction | ... | Q282629 (vinblastine) | vinblastine |
| P3364 | stereoisomer of | ... | Q27166462 (LSM-5621) | LSM-5621 |
| P279 | subclass of | ... | Q27163543 (LSM-1590) | LSM-1590 |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q17172594 (alkylating agent) | alkylating agent |
| P2868 | subject has role | ... | Q50429956 (cross-linking reagent) | cross-linking reagent |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q4381760 (antineoplastic antibiotics) | antineoplastic antibiotics |
Why not click here or view trends?
log id: 2037183